A Treatment for Monkeypox?

Monkeypox is the newest worldwide pandemic and closely mirrors both COVID-19 and HIV pandemics. A large difference is theoretical vaccines and treatments for monkeypox already exist. In this episode of GameChangers, host Geoff Wall, evaluates tecovirimat, a potential monkeypox treatment and the regulations that made it possible. The GameChanger Little to no randomized controlled data exist on tecovirimat’s safety and efficacy in monkeypox. A recent case series helps establish the safety of tecovirimat for monkeypox use. Show Segments 00:00 - Introductions 02:40 - Current Issue of Monkeypox 04:02 - Tecovirimat “Animal Rule” 11:19 - The GameChanger: Tecovirimat Case Series 17:20 - Applying to Practice 20:45 - Closing Remarks Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health References and resources: Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection. Redeem your CPE or CME credit CPE (Pharmacist) CME (Physician) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a Membership Prescribers: Get a Membership Continuing Education Information: Learning Objectives: 1. Describe the development and use of tecovirimat under the “Animal Rule” 2. Discuss the latest report of tecovirimat use in US patients with monkeypox All relevant financial relationships have been mitigated. 0.05 CEU | 0.5 Hrs ACPE UAN: 0107-0000-22-354-H01-P Initial release date: 09/26/22 Expiration date: 09/26/2023 Additional CPE & CME details can be found here Follow CEimpact on Social Media: LinkedIn Instagram